Elemer Piros
Stock Analyst at Lucid Capital
(0.07)
# 4,839
Out of 5,125 analysts
353
Total ratings
34.8%
Success rate
-8.6%
Average return
Main Sectors:
Stocks Rated by Elemer Piros
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| FLNA Filana Therapeutics | Reiterated: Buy | $8 | $0.4823 | +1,558.72% | 6 | Sep 22, 2026 | |
| TVRD Tvardi Therapeutics | Initiated Coverage: Buy | $14 | $1.41 | +892.91% | 1 | Sep 8, 2026 | |
| AZR Azora Therapeutics | Initiated Coverage: Buy | $6 | $3.76 | +59.57% | 1 | Jun 15, 2026 | |
| NRXP NRx Pharmaceuticals | Initiated Coverage: Buy | $49 | $2.36 | +1,976.27% | 1 | May 13, 2026 | |
| PASG Passage Bio | Downgraded: Hold | $68 → $9 | $3.78 | +138.10% | 3 | Apr 20, 2026 | |
| INMB INmune Bio | Upgraded: Buy | $2 → $9 | $1.10 | +718.18% | 4 | Mar 11, 2026 | |
| OCGN Ocugen | Reiterated: Buy | $15 → $22 | $0.95 | +2,215.79% | 2 | Mar 11, 2026 | |
| IRLA IRulya Therapeutics | Downgraded: Sell | n/a | $38.62 | - | 1 | Jan 30, 2026 | |
| MNOV MediciNova | Initiated Coverage: Buy | $11 | $1.40 | +685.71% | 1 | Jan 5, 2026 | |
| VTGN Vistagen Therapeutics | Downgraded: Hold | $19 → $1 | $0.1831 | +446.15% | 2 | Dec 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | n/a | $9.18 | - | 1 | Dec 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $81 → $2.3 | $2.69 | n/a | 2 | Oct 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $20 | $3.16 | n/a | 7 | Sep 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $5.5 | $2.80 | n/a | 1 | Aug 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $13 | $1.38 | n/a | 1 | Jul 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $8 | $0.6102 | n/a | 1 | Jul 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $50 | $9.62 | n/a | 1 | Jun 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $50 → $71 | $71.78 | n/a | 7 | Jun 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $5 → $120 | $3.66 | n/a | 4 | Jun 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $15 | $0.5721 | n/a | 1 | Feb 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $42 → $36 | $19.56 | n/a | 5 | Feb 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $30 → $9 | $9.25 | n/a | 12 | Jan 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $12 | $0.9239 | n/a | 1 | Dec 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $17 | $1.86 | n/a | 1 | Dec 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $43 → $5.5 | $28.61 | n/a | 2 | Oct 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $17 | $0.6209 | n/a | 1 | Sep 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $22 → $0.75 | $4.02 | n/a | 2 | Sep 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $67 | $0.8743 | n/a | 1 | Jul 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $14 | $0.6702 | n/a | 1 | Jun 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $455 | $1.61 | n/a | 1 | Jun 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $21 → $28 | $34.64 | n/a | 8 | Apr 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $68 | $0.3412 | n/a | 1 | May 31, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $40 | $0.5738 | n/a | 1 | May 31, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $14 | $0.38 | n/a | 1 | May 31, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $11 → $13 | $4.41 | n/a | 7 | Mar 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $32 → $24 | $9.67 | n/a | 3 | Oct 27, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $1.22 → $1.79 | $3.93 | n/a | 41 | Mar 15, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | $77 → $45 | $9.39 | n/a | 5 | Mar 2, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $9 | $0.6921 | n/a | 1 | Jan 11, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $14 → $8 | $0.11817 | n/a | 2 | Dec 1, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $23 | $13.99 | n/a | 16 | Sep 10, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $29 → $2 | $2.46 | n/a | 33 | Aug 12, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $81 → $94 | $22.71 | n/a | 16 | Jul 8, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $24 | $49.00 | n/a | 24 | Jun 27, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $35 → $33 | $0.6291 | n/a | 17 | Jun 25, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $34 → $67 | $306.50 | n/a | 8 | Jun 24, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $7 | $0.4506 | n/a | 1 | Jun 20, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $7 | $43.91 | n/a | 14 | May 7, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $18 → $24 | $16.30 | n/a | 26 | Mar 19, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $24 | $6.61 | n/a | 16 | Mar 7, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $236.19 | n/a | 16 | May 4, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $19 | $17.30 | n/a | 16 | Mar 1, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $7 | $168.71 | n/a | 3 | Mar 23, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | n/a | $3.38 | n/a | 1 | Mar 9, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $71.25 | n/a | 1 | Feb 15, 2012 |
Filana Therapeutics
Sep 22, 2026
Reiterated: Buy
Price Target: $8
Current: $0.4823
Upside: +1,558.72%
Tvardi Therapeutics
Sep 8, 2026
Initiated Coverage: Buy
Price Target: $14
Current: $1.41
Upside: +892.91%
Azora Therapeutics
Jun 15, 2026
Initiated Coverage: Buy
Price Target: $6
Current: $3.76
Upside: +59.57%
NRx Pharmaceuticals
May 13, 2026
Initiated Coverage: Buy
Price Target: $49
Current: $2.36
Upside: +1,976.27%
Passage Bio
Apr 20, 2026
Downgraded: Hold
Price Target: $68 → $9
Current: $3.78
Upside: +138.10%
INmune Bio
Mar 11, 2026
Upgraded: Buy
Price Target: $2 → $9
Current: $1.10
Upside: +718.18%
Ocugen
Mar 11, 2026
Reiterated: Buy
Price Target: $15 → $22
Current: $0.95
Upside: +2,215.79%
IRulya Therapeutics
Jan 30, 2026
Downgraded: Sell
Price Target: n/a
Current: $38.62
Upside: -
MediciNova
Jan 5, 2026
Initiated Coverage: Buy
Price Target: $11
Current: $1.40
Upside: +685.71%
Vistagen Therapeutics
Dec 17, 2025
Downgraded: Hold
Price Target: $19 → $1
Current: $0.1831
Upside: +446.15%
Dec 11, 2025
Initiated Coverage: Buy
Price Target: n/a
Current: $9.18
Upside: -
Oct 21, 2025
Downgraded: Hold
Price Target: $81 → $2.3
Current: $2.69
Upside: n/a
Sep 22, 2025
Reiterated: Buy
Price Target: $20
Current: $3.16
Upside: n/a
Aug 13, 2025
Initiated Coverage: Buy
Price Target: $5.5
Current: $2.80
Upside: n/a
Jul 31, 2025
Initiated Coverage: Buy
Price Target: $13
Current: $1.38
Upside: n/a
Jul 22, 2025
Initiated Coverage: Buy
Price Target: $8
Current: $0.6102
Upside: n/a
Jun 9, 2025
Initiated Coverage: Buy
Price Target: $50
Current: $9.62
Upside: n/a
Jun 5, 2025
Initiated Coverage: Buy
Price Target: $50 → $71
Current: $71.78
Upside: n/a
Jun 4, 2025
Initiated Coverage: Buy
Price Target: $5 → $120
Current: $3.66
Upside: n/a
Feb 20, 2025
Initiated Coverage: Buy
Price Target: $15
Current: $0.5721
Upside: n/a
Feb 7, 2025
Reiterated: Buy
Price Target: $42 → $36
Current: $19.56
Upside: n/a
Jan 27, 2025
Reiterated: Buy
Price Target: $30 → $9
Current: $9.25
Upside: n/a
Dec 11, 2024
Initiated Coverage: Buy
Price Target: $12
Current: $0.9239
Upside: n/a
Dec 6, 2024
Initiated Coverage: Buy
Price Target: $17
Current: $1.86
Upside: n/a
Oct 23, 2024
Downgraded: Hold
Price Target: $43 → $5.5
Current: $28.61
Upside: n/a
Sep 30, 2024
Initiated Coverage: Buy
Price Target: $17
Current: $0.6209
Upside: n/a
Sep 4, 2024
Downgraded: Hold
Price Target: $22 → $0.75
Current: $4.02
Upside: n/a
Jul 2, 2024
Reiterated: Buy
Price Target: $67
Current: $0.8743
Upside: n/a
Jun 13, 2024
Initiated Coverage: Buy
Price Target: $14
Current: $0.6702
Upside: n/a
Jun 12, 2024
Initiated Coverage: Buy
Price Target: $455
Current: $1.61
Upside: n/a
Apr 4, 2024
Reiterated: Buy
Price Target: $21 → $28
Current: $34.64
Upside: n/a
May 31, 2023
Initiated Coverage: Buy
Price Target: $68
Current: $0.3412
Upside: n/a
May 31, 2023
Initiated Coverage: Buy
Price Target: $40
Current: $0.5738
Upside: n/a
May 31, 2023
Initiated Coverage: Buy
Price Target: $14
Current: $0.38
Upside: n/a
Mar 8, 2023
Initiated Coverage: Buy
Price Target: $11 → $13
Current: $4.41
Upside: n/a
Oct 27, 2021
Reiterated: Buy
Price Target: $32 → $24
Current: $9.67
Upside: n/a
Mar 15, 2021
Reiterated: Hold
Price Target: $1.22 → $1.79
Current: $3.93
Upside: n/a
Mar 2, 2021
Reiterated: Sell
Price Target: $77 → $45
Current: $9.39
Upside: n/a
Jan 11, 2021
Reiterated: Buy
Price Target: $9
Current: $0.6921
Upside: n/a
Dec 1, 2020
Reiterated: Buy
Price Target: $14 → $8
Current: $0.11817
Upside: n/a
Sep 10, 2019
Reiterated: Buy
Price Target: $23
Current: $13.99
Upside: n/a
Aug 12, 2019
Downgraded: Hold
Price Target: $29 → $2
Current: $2.46
Upside: n/a
Jul 8, 2019
Reiterated: Buy
Price Target: $81 → $94
Current: $22.71
Upside: n/a
Jun 27, 2019
Downgraded: Hold
Price Target: $24
Current: $49.00
Upside: n/a
Jun 25, 2019
Reiterated: Buy
Price Target: $35 → $33
Current: $0.6291
Upside: n/a
Jun 24, 2019
Reiterated: Buy
Price Target: $34 → $67
Current: $306.50
Upside: n/a
Jun 20, 2019
Initiated Coverage: Buy
Price Target: $7
Current: $0.4506
Upside: n/a
May 7, 2019
Reiterated: Buy
Price Target: $7
Current: $43.91
Upside: n/a
Mar 19, 2019
Reiterated: Buy
Price Target: $18 → $24
Current: $16.30
Upside: n/a
Mar 7, 2019
Reiterated: Buy
Price Target: $24
Current: $6.61
Upside: n/a
May 4, 2018
Reiterated: Hold
Price Target: n/a
Current: $236.19
Upside: n/a
Mar 1, 2018
Reiterated: Hold
Price Target: $19
Current: $17.30
Upside: n/a
Mar 23, 2016
Reiterated: Buy
Price Target: $7
Current: $168.71
Upside: n/a
Mar 9, 2016
Initiated Coverage: Buy
Price Target: n/a
Current: $3.38
Upside: n/a
Feb 15, 2012
Reiterated: Hold
Price Target: n/a
Current: $71.25
Upside: n/a